Mallinckrodt Pharmaceuticals

Exhibitor

Ikaria Australia is now a part of Mallinckrodt Pharmaceuticals. Mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents.  

Currently, INOmax® (nitric oxide) for inhalation and Lucassin® (terlipressin) are Ikaria’s commercialized products in Australia.  Ikaria Australia is dedicated to support Australian research due to the company’s strategic vision of being a valued partner in Critical Care.  At Ikaria Australia, we look forward to expanding our product portfolio to address the unmet needs of Australian patients and clinicians in the near future. 

www.mallinckrodt.com/

View all sponsors